Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 134 contracts
Samples: Sales Agreement (Mind Medicine (MindMed) Inc.), Sales Agreement (Cytokinetics Inc), Cef Purchase Agreement (Lucid Diagnostics Inc.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 126 contracts
Samples: Financing Agreement (Luminar Technologies, Inc./De), Common Stock (Nanoviricides, Inc.), Sales Agreement (Cumberland Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 57 contracts
Samples: Sales Agreement (vTv Therapeutics Inc.), Sales Agreement (Galmed Pharmaceuticals Ltd.), Sales Agreement (Ocugen, Inc.)
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 37 contracts
Samples: Sales Agreement (Evolution Petroleum Corp), Sales Agreement (PLBY Group, Inc.), Sales Agreement (Sonim Technologies Inc)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 33 contracts
Samples: Sales Agreement (CorMedix Inc.), CorMedix Inc., Common Stock (Tg Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of Subsidiary, nor, to the SubsidiariesCompany’s knowledge, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 28 contracts
Samples: Sales Agreement (LIGHTBRIDGE Corp), Moleculin Biotech, Inc., Moleculin Biotech, Inc.
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 25 contracts
Samples: Market Issuance Sales Agreement (Geron Corp), Geron Corp, Stellus Capital Investment Corp
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 20 contracts
Samples: Common Stock (Enzo Biochem Inc), Gryphon Digital Mining, Inc., Market Issuance Sales Agreement (Neonode Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 19 contracts
Samples: Sales Agreement (Perspective Therapeutics, Inc.), Sales Agreement (Semler Scientific, Inc.), Sales Agreement (Invivyd, Inc.)
Certain Market Activities. Neither the Company, nor Company or any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 16 contracts
Samples: Common Stock (RDE, Inc.), Common Stock (Aclarion, Inc.), Common Stock (Oragenics Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their its respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 14 contracts
Samples: Market Issuance Sales Agreement (Xoma LTD /De/), Peregrine Pharmaceuticals Inc, Peregrine Pharmaceuticals Inc
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor to the knowledge of the Company any of their respective directors, directors or officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act Act, Canadian Securities Laws or otherwise, the stabilization stabilization, maintenance or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 14 contracts
Samples: Underwriting Agreement (Western Copper & Gold Corp), Underwriting Agreement (Northern Dynasty Minerals LTD), Underwriting Agreement (Northern Dynasty Minerals LTD)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 13 contracts
Samples: Sales Agreement (Soleno Therapeutics Inc), Vision Marine Technologies Inc., Paramount Gold Nevada Corp.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 12 contracts
Samples: Sales Agreement (Volta Inc.), Sales Agreement (Opiant Pharmaceuticals, Inc.), Sales Agreement (Delcath Systems, Inc.)
Certain Market Activities. Neither the Company, nor Company or any of the Subsidiaries, nor any of their respective directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 10 contracts
Samples: Common Stock (Ault Alliance, Inc.), Sales Agreement (SciSparc Ltd.), Common Stock (Ault Global Holdings, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 10 contracts
Samples: NightHawk Biosciences, Inc., Sales Agreement (Cyclacel Pharmaceuticals, Inc.), Synthetic Biologics, Inc.
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor to the knowledge of the Company any of their respective directors, directors or officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act Act, Canadian Securities Laws or otherwise, the stabilization stabilization, maintenance or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesUnits.
Appears in 10 contracts
Samples: Underwriting Agreement (Draganfly Inc.), Underwriting Agreement (Draganfly Inc.), Underwriting Agreement (Vista Gold Corp)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 9 contracts
Samples: Sales Agreement (Anixa Biosciences Inc), Sales Agreement (Cyclacel Pharmaceuticals, Inc.), Sales Agreement (Verastem, Inc.)
Certain Market Activities. Neither the Company, Company nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 9 contracts
Samples: Sales Agreement (Forty Seven, Inc.), Sales Agreement (Forty Seven, Inc.), Celsion CORP
Certain Market Activities. Neither the Company, any Subsidiary nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Equity Distribution Agreement (Inspirato Inc), Lexaria Bioscience Corp., Elicio Therapeutics, Inc.
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the its Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Sales Agreement (Sunesis Pharmaceuticals Inc), Sales Agreement (Sunesis Pharmaceuticals Inc), Sales Agreement (Sunesis Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Sales Agreement (Lineage Cell Therapeutics, Inc.), Sales Agreement (AgeX Therapeutics, Inc.), Sales Agreement (Lineage Cell Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Distribution Agency Agreement (Tellurian Inc. /De/), Distribution Agency Agreement (Tellurian Inc. /De/), Securities Purchase Agreement (Tellurian Inc. /De/)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesOffered Securities.
Appears in 7 contracts
Samples: Placement Agent Agreement (Tellurian Inc. /De/), Placement Agent Agreement (Tellurian Inc. /De/), Underwriting Agreement (Tellurian Inc. /De/)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 6 contracts
Samples: Sales Agreement (eFFECTOR Therapeutics, Inc.), Sales Agreement (CareCloud, Inc.), Sales Agreement (CareCloud, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 6 contracts
Samples: Array Biopharma (Array Biopharma Inc), Array Biopharma (Array Biopharma Inc), Sales Agreement (CollabRx, Inc.)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 5 contracts
Samples: Sales Agreement (Actinium Pharmaceuticals, Inc.), Original Sales Agreement (Actinium Pharmaceuticals, Inc.), Sales Agreement (Actinium Pharmaceuticals, Inc.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 5 contracts
Samples: Investment Agreement (Perspective Therapeutics, Inc.), Investment Agreement (Perspective Therapeutics, Inc.), Achieve Life Sciences, Inc.
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 5 contracts
Samples: American Superconductor Corp /De/, Ashford Inc., Sorrento Therapeutics, Inc.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 4 contracts
Samples: Underwriting Agreement (Protagonist Therapeutics, Inc), Theratechnologies Inc., Underwriting Agreement (Cellular Biomedicine Group, Inc.)
Certain Market Activities. Neither the Company, any Subsidiary nor any of the Subsidiaries, nor any of their respective its directors, officers or or, to the Company’s knowledge, controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Virios Therapeutics, Inc., NEUROONE MEDICAL TECHNOLOGIES Corp, Ocuphire Pharma, Inc.
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their its respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (Ardelyx, Inc.), Sales Agreement (Ardelyx, Inc.), Sales Agreement (Signal Genetics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Open Market Sale (Protagonist Therapeutics, Inc), Market Sale (Cytosorbents Corp), Open Market Sale (Protagonist Therapeutics, Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Izea Worldwide (IZEA Worldwide, Inc.), Izea Worldwide (IZEA Worldwide, Inc.), Global Self (Global Self Storage, Inc.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Underwriting Agreement (MTBC, Inc.), Underwriting Agreement (MTBC, Inc.), Underwriting Agreement (MTBC, Inc.)
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor to the knowledge of the Company any of their respective directors, directors or officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization stabilization, maintenance or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc)
Certain Market Activities. Neither the Company, Company nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (Emerald Oil, Inc.), Common Stock (Emerald Oil, Inc.), Sales Agreement (PostRock Energy Corp)
Certain Market Activities. Neither the CompanyCompany nor any Subsidiary, nor to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Monopar Therapeutics, Monopar Therapeutics, Catalyst Biosciences, Inc.
Certain Market Activities. Neither To the Company’s knowledge, neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (Heat Biologics, Inc.), Sales Agreement (Sucampo Pharmaceuticals, Inc.), Ligand Pharmaceuticals Inc
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesSecurities.
Appears in 4 contracts
Samples: Underwriting Agreement (Protagonist Therapeutics, Inc), Mind Medicine (MindMed) Inc., Underwriting Agreement (Protagonist Therapeutics, Inc)
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Immucell Corp /De/), Securities Purchase Agreement (Immucell Corp /De/), Securities Purchase Agreement (Transwitch Corp /De)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Unilife Corp), Pdi Inc, Unilife Corp
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has takentaken or will take, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesStock.
Appears in 3 contracts
Samples: Underwriting Agreement (American Superconductor Corp /De/), Underwriting Agreement (American Superconductor Corp /De/), Underwriting Agreement (American Superconductor Corp /De/)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the Knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Ur-Energy Inc, Ur-Energy Inc, Ur-Energy Inc
Certain Market Activities. Neither the Company, nor nor, to the knowledge of the Company, any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Correvio Pharma Corp., Cardiome Pharma Corp, Cardiome Pharma Corp
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Avino Silver & Gold Mines LTD)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons persons, has taken, directly or indirectly, any action designeddesigned to, or that has constituted constituted, or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Lumos Pharma, Inc., Newlink Genetics Corp, Newlink Genetics Corp
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares or any Forward Settlement Shares.
Appears in 3 contracts
Samples: Terms Agreement (Global Medical REIT Inc.), Terms Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.)
Certain Market Activities. Neither the Company, nor any of the its Subsidiaries, nor any of their respective directors, officers or controlling persons has have taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Akebia Therapeutics, Inc.), Akebia Therapeutics, Inc., Akebia Therapeutics, Inc.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Forte Biosciences, Inc., Forte Biosciences, Inc., Bionano Genomics, Inc
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Oncogenex Pharmaceuticals, Inc.), Acura Pharmaceuticals, Inc, Omeros Corp
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act, the ASX Listing Rules, the Corporations Act or otherwiseother relevant law, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Alterity Therapeutics LTD, Prana Biotechnology LTD, Prana Biotechnology LTD
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Biovie Inc.), Titan Pharmaceuticals Inc, Ascent Solar Technologies, Inc.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designeddesigned to, that has constituted, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Archer Aviation Inc.), Sales Agreement (Rubicon Technologies, Inc.), Sales Agreement (Rubicon Technologies, Inc.)
Certain Market Activities. Neither the Company, any Subsidiary nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesSecurities.
Appears in 2 contracts
Samples: Underwriting Agreement (CalciMedica, Inc.), Underwriting Agreement (Elicio Therapeutics, Inc.)
Certain Market Activities. Neither the Company, Company nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Gastar Exploration Inc., ZaZa Energy Corp
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directorstrustees, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: RAIT Financial Trust, RAIT Financial Trust
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (Sangamo Biosciences Inc), Sales Agreement (Introgen Therapeutics Inc)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwiseother relevant law, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Common Shares and/or Preferred Shares.
Appears in 2 contracts
Samples: Chicken Soup for the Soul Entertainment, Inc., Chicken Soup for the Soul Entertainment, Inc.
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Common Stock (Alzamend Neuro, Inc.), Common Stock (Alzamend Neuro, Inc.)
Certain Market Activities. Neither the Company, nor to the Company’s knowledge, any of the Subsidiariesits affiliates, nor any of their respective directors, officers has taken or controlling persons has takenmay take, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Anworth Mortgage Asset Corp, Anworth Mortgage Asset Corp
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their its respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Certain Market Activities. Neither the Company, nor to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: ARCA Biopharma, Inc., ARCA Biopharma, Inc.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or nor, to the Company’s knowledge, any controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Orchids Paper Products CO /DE), Orexigen Therapeutics, Inc.
Certain Market Activities. Neither the Company, nor any its Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (Verastem, Inc.), Sales Agreement (Verastem, Inc.)
Certain Market Activities. Neither the Company nor, to the Company's knowledge, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (GREENPOWER MOTOR Co INC.), Sales Agreement (ALKALINE WATER Co INC)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons persons, has taken, directly or indirectly, any action designeddesigned to constitute, or that has constituted or might reasonably be expected to cause or result inconstituted, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate for the purpose of facilitating the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Spectrum Pharmaceuticals Inc, Spectrum Pharmaceuticals Inc
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwiseother applicable law, the stabilization or manipulation of the price of any security of the Company Common Stock to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Trinity Place Holdings Inc., Teligent, Inc.
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has have taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Pluristem Therapeutics Inc, Pluristem Therapeutics Inc
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesSecurities.
Appears in 2 contracts
Samples: Securities Purchase Agreement (pSivida Corp.), Second Securities Purchase Agreement (pSivida Corp.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Standard Diversified Inc., Aeglea BioTherapeutics, Inc.
Certain Market Activities. Neither the Company, nor any of Subsidiary, nor, to the SubsidiariesCompany’s knowledge, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: ViewRay, Inc., ViewRay, Inc.
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange 1934 Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Common Shares.
Appears in 2 contracts
Samples: Underwriting Agreement (Stellus Capital Investment Corp), Underwriting Agreement (Stellus Capital Investment Corp)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Underwriting Agreement (Biotime Inc), Underwriting Agreement (Asterias Biotherapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Management Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Underwriting Agreement (Forte Biosciences, Inc.), Meta Materials Inc.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares; however, the Company makes no representation with respect to any actions taken by the Agent.
Appears in 2 contracts
Samples: Paratek Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or or, to the Company’s knowledge, controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (Caledonia Mining Corp PLC), Caledonia Mining Corp PLC
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or nor, to the Company’s knowledge, any controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (HTG Molecular Diagnostics, Inc), Sales Agreement (HTG Molecular Diagnostics, Inc)
Certain Market Activities. Neither the Company, any Subsidiary nor to the Company’s knowledge any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: HCW Biologics Inc.
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Wireless Telecom Group Inc
Certain Market Activities. Neither the Company, nor any of the Subsidiariessubsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Sales Agreement (Nyxoah SA)
Certain Market Activities. Neither To the Company’s knowledge, neither the Company nor any of the Subsidiaries, nor any of their respective directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Sales Agreement (Phunware, Inc.)
Certain Market Activities. Neither the Company, Company nor any of the its Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Equity Distribution Agreement (Repros Therapeutics Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Certain Market Activities. Neither the Company, nor any of the Subsidiariesits Subsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designeddesigned to, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwisesecurities laws applicable to the Company, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 1 contract
Samples: Underwriting Agreement (Zomedica Pharmaceuticals Corp.)
Certain Market Activities. Neither the Company, Company nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons persons, has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Lakeland Bancorp Inc
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their its respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesSecurities.
Appears in 1 contract
Samples: Underwriting Agreement (Peregrine Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 1 contract
Samples: Underwriting Agreement (iBio, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, the Subsidiaries, nor any of the SubsidiariesManager, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Certain Market Activities. Neither the Company, any Subsidiary nor any of its directors or officers or, to the SubsidiariesCompany’s knowledge, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: BioRestorative Therapies, Inc.
Certain Market Activities. Neither the Company, nor any of the Subsidiariessubsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 1 contract
Samples: Underwriting Agreement (Spectrum Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, Subsidiary nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Cassava Sciences Inc
Certain Market Activities. Neither the Company, nor Company or any of the Subsidiaries, nor any of their respective directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesADSs.
Appears in 1 contract
Samples: Medigus Ltd.
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company's knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Snow Lake Resources Ltd.
